Fosun Pharma, CanSino take different paths as Covid lift fade
The pair of companies that got strong shots from different Covid vaccines are telling different stories in their latest quarterly results as the pandemic draws down Key Takeaways: Fosun Pharma’s…
Recent Articles
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK
6185.HK
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Fosun moves on from debt crisis with renewed focus on tourism, healthcare
0656.HK
-
Fosun Tourism travels back to home base with delisting plan
1992.HK 0656.HK
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
